Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis ?
Wai-Tong NgMatthew Chin Heng ChuaAnne Wing-Mui LeePublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)